Jason Knight, MD, Connects Via The RP-VITA Telemedicine Robot To Remotely Examine An ER Patient During A Clinical Validation Process At Hoag Hospital. The RP-VITA Was Developed By InTouch Health And IRobot. (Photo: Business Wire)

InTouch Health, the leader in acute care remote presence telemedicine, and iRobot (NASDAQ: IRBT), a leader in delivering robotic technology-based solutions, today announced the companies will unveil the breakthrough RP-VITA (Remote Presence Virtual + Independent Telemedicine Assistant) at the InTouch Health 7 ^th Annual Clinical Innovations Forum, to be held July 26 – 28 in Santa Barbara, CA. The RP-VITA is the first remote presence solution for patient care that combines the latest in telemedicine technology from InTouch Health with the latest in autonomous navigation and mobility developed for the iRobot Ava™ mobile robotics platform. For the hospital market, the RP-VITA improves patient care by ensuring the physician is in the right place at the right time and has access to the necessary clinical information to take immediate action.

Jason Knight, MD, connects via the RP-VITA telemedicine robot to remotely examine an ER patient during a clinical validation process at Hoag Hospital. The RP-VITA was developed by InTouch Health and iRobot. (Photo: Business Wire)

The RP-VITA is a result of a joint development and licensing agreement the two best-of-breed companies announced a year ago and broadened earlier this year. An expandable telemedicine technology platform, the RP-VITA is the remote presence device component of a total acute care telemedicine solution which includes an integrated ecosystem of technologies and support infrastructure, all part of the InTouch® Telemedicine System. The RP-VITA will be sold by InTouch Health as its new flagship remote presence device. iRobot will continue to explore adjacent market opportunities for robots like the RP-VITA and iRobot Ava.

“The hospital industry is undergoing significant changes, and as we strive to maintain our culture of ensuring an excellent patient experience, we face significant pressure on reducing operating expenses and managing staffing and resources. New technology such as the RP-VITA that dramatically increases the effectiveness and extends the reach of healthcare professionals is required,” said Richard Afable, M.D., M.P.H., President of and CEO of Hoag Memorial Hospital Presbyterian. Hoag, Ronald Reagan UCLA Medical Center and Children’s Hospital of Orange County (CHOC) participated in clinical validations as part of the U.S. Food and Drug Administration (FDA) review process for the RP-VITA.

1 2 3 4 Next › Last »